Viewing Study NCT05849857


Ignite Creation Date: 2025-12-24 @ 6:42 PM
Ignite Modification Date: 2025-12-26 @ 5:38 PM
Study NCT ID: NCT05849857
Status: RECRUITING
Last Update Posted: 2023-11-01
First Post: 2023-03-22
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Mosunetuzumab for Early Relapse of Follicular Lymphoma in the Nordic Countries
Sponsor: Oslo University Hospital
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module